Michael Wilson

Michael Wilson is an Associate Professor in Applied Respiratory Physiology within the Department of Surgery & Cancer, Faculty of Medicine, at Imperial College London. Based at G.3.43, Chelsea and Westminster Hospital, he is affiliated with the Critical Care Anaesthetics, Pain Medicine and Intensive Care (APMIC) stream and maintains an active role in both research and teaching.

Education:

• PhD from Imperial College London (St. Mary's Hospital), 1998
• Postdoctoral research at King's College London
• Postdoctoral research at Queen Mary University of London

Dr. Wilson's research centers on pulmonary aspects of critical care, specifically investigating inflammatory mechanisms in acute lung injury within intensive care units. His work explores ventilator-induced lung injury (VILI) pathophysiology, TNF signaling pathways, monocyte/macrophage dynamics, and advanced modeling techniques. This research spans Clinical Sciences, Physiology, Immunology, and Biochemistry, addressing critical gaps in understanding how inflammatory responses drive lung injury progression.

Scientific Awards:

• No scientific awards documented in the provided text.

As Course Director for the BSc in Anaesthesia & Critical Care and joint lead for the APMIC stream of the MRes in Biomedical Research, Dr. Wilson shapes curriculum development and student training. His industrial partnerships with GlaxoSmithKline (since 2008) and NeRRe therapeutics (since 2020) demonstrate sustained translational research engagement, likely supporting grant-funded projects bridging academic and commercial critical care innovation.

He contributes to the Critical Care Research group under Professor Masao Takata, focusing on collaborative investigations into respiratory pathophysiology and therapeutic interventions for intensive care settings.